Pharmaceutical - Santen Pharmaceuticals


Current filters:

Santen Pharmaceuticals

Popular Filters

Santen and TRACON link up for TRC105 in ophthalmology


USA-based TRACON Pharmaceuticals and Japan’s Santen Pharmaceutical have entered into an exclusive agreement…

LicensingPharmaceuticalSanten PharmaceuticalsTRACON PharmaceuticalsTRC105

Akorn gains rights to Betimol from Santen


US niche generic firm Akorn has acquired the New Drug Application and all rights to Betimol (timolol…

AkornBetimolMergers & AcquisitionsOphthalmicsPharmaceuticalSanten Pharmaceuticals

Bayer files for Japanese approval of Eylea for macular edema following CRVO


German drug major Bayer(BAYN: DE) says its subsidiary Bayer Yakuhin has applied to the Japanese Ministry…

afliberceptAsia-PacificBayerBiotechnologyEyleaOphthalmicsPharmaceuticalRegeneronRegulationSanten Pharmaceuticals

Santen in ophthalmics deal with Eisai; Sets up new company in China


Japan's Santen Pharmaceutical (TYO: 4536) has entered into an option agreement with drug major Eisai…

Asia-PacificEisaiLicensingMarkets & MarketingOphthalmicsPharmaceuticalSanten Pharmaceuticals

Santen to co-promote Bayer and Regeneron's Eylea in Japan


German drug major Bayer's (BAYN: DE) Japanese subsidiary, Bayer Yakuhin, and Santen Pharmaceutical (TYO:…

Asia-PacificBayerEyleaLicensingMarkets & MarketingOphthalmicsPharmaceuticalRegeneronSanten Pharmaceuticals

FDA approves Merck & Co’s Zioptan


The US Food and Drug Administration) has approved drug giant Merck & Co’s (NYSE: MRK) Zioptan (tafluprost…

Merck & CoNorth AmericaOphthalmicsPharmaceuticalRegulationSaflutanSanten PharmaceuticalsZioptan

Mixed half-year results from Astellas, Eisai and Santen


Compared with some of its peers which reported first-half fiscal year 2011/12 (ended September 30) financial…

Astellas PharmaEisaiFinancialPharmaceuticalSanten Pharmaceuticals

Santen Pharma progresses acquisition of Novagali, gaining 50.55% stake


Japanese drugmaker Santen Pharmaceuticals (TYO: 4536) says it has completed its previously-announced…

Mergers & AcquisitionsNovagaliOphthalmicsPharmaceuticalSanten Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top